BMAL1 and melanoma: To determine whether time-modulated drug activity on the mouse melanoma was core clock dependent, we generated CRISPR-control (B16-CTL) and Bmal1 knockout (B16-Bmal1-KO) melanoma cells stably expressing Per2 promoter–driven luciferase (pPer2-dLuc) (Fig. 5C).